Cargando…
Promises and challenges of adoptive T-cell therapies for solid tumours
Cancer is a leading cause of death worldwide and, despite new targeted therapies and immunotherapies, many patients with advanced-stage- or high-risk cancers still die, owing to metastatic disease. Adoptive T-cell therapy, involving the autologous or allogeneic transplant of tumour-infiltrating lymp...
Autores principales: | Morotti, Matteo, Albukhari, Ashwag, Alsaadi, Abdulkhaliq, Artibani, Mara, Brenton, James D., Curbishley, Stuart M., Dong, Tao, Dustin, Michael L., Hu, Zhiyuan, McGranahan, Nicholas, Miller, Martin L., Santana-Gonzalez, Laura, Seymour, Leonard W., Shi, Tingyan, Van Loo, Peter, Yau, Christopher, White, Helen, Wietek, Nina, Church, David N., Wedge, David C., Ahmed, Ahmed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144577/ https://www.ncbi.nlm.nih.gov/pubmed/33782566 http://dx.doi.org/10.1038/s41416-021-01353-6 |
Ejemplares similares
-
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct
por: Santana Gonzalez, Laura, et al.
Publicado: (2021) -
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
por: Motohara, Takeshi, et al.
Publicado: (2018) -
Correction to: An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
por: Motohara, Takeshi, et al.
Publicado: (2022) -
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
por: Artibani, Mara, et al.
Publicado: (2021) -
A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes
por: Carrami, Eli M, et al.
Publicado: (2020)